A ratiometric fluorescent probe based on quinoline for monitoring and imaging of Leucine aminopeptidase in liver tumor cells

Copyright © 2020. Published by Elsevier B.V..

Leucine aminopeptidase (LAP) is known as an important potential biomarker for liver malignancy and it is urgent to develop an intuitive and effective method to monitor the activity of LAP in liver cancer. Although, numerous LAP fluorescent probes had been developed, it is still a challenge to detect LAP activity in liver cancer. Herein, combained with the DFT, we reported a novel galactose-appended hepatoma-specific ratiometric fluorescent probe (Gal-QL-Leu) based on quinoline group for imaging and tracing LAP in liver tumor cells. Probe Gal-QL-Leu demonstrated a obvious ratiometric characteristics, better selectivity, good biocompatibility and high sensitivity. Moreover, the selective imaging of LAP in HepG2, HCT116, A549 and HeLa cells had been achieved with probe Gal-QL-Leu, demonstrating good application prospect in the detection of LAP activity in liver tumor cells.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:249

Enthalten in:

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy - 249(2021) vom: 15. März, Seite 119328

Sprache:

Englisch

Beteiligte Personen:

Du, Kui [VerfasserIn]
Sheng, Li [VerfasserIn]
Luo, Xiang [VerfasserIn]
Fan, Gang [VerfasserIn]
Shen, Dadong [VerfasserIn]
Wu, Chunlei [VerfasserIn]
Shen, Runpu [VerfasserIn]

Links:

Volltext

Themen:

EC 3.4.11.1
Fluorescent Dyes
Hepatoma-specific
Journal Article
Leucine aminopeptidase
Leucyl Aminopeptidase
Liver cancer
Quinoline
Quinolines
Ratiometric

Anmerkungen:

Date Completed 14.05.2021

Date Revised 14.05.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.saa.2020.119328

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM319245330